NASDAQ: CLSDClearside Biomedical Inc Stock Ownership - Who owns Clearside Biomedical?
Insider buying vs selling
Have Clearside Biomedical Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Anthony S. Gibney | Director | 2024-04-18 | 93,290 | $1.30 | $121.28kBuy |
| Anthony S. Gibney | Director | 2024-04-17 | 6,710 | $1.25 | $8.39kBuy |
| Ngai Hang Victor Chong | CHIEF MEDICAL OFFICER | 2024-03-20 | 30,000 | $1.60 | $48.00kBuy |
| Bradford T. Whitmore | 10% Owner | 2024-02-07 | 444,444 | $1.35 | $600.00kBuy |
| George M. Lasezkay | CEO | 2024-01-19 | 18,000 | $1.27 | $22.86kSell |
| Charles A. Deignan | Chief Financial Officer | 2024-01-19 | 12,900 | $1.28 | $16.51kSell |
| Bradford T. Whitmore | 10% Owner | 2023-11-01 | 64,366 | $0.74 | $47.89kBuy |
| Bradford T. Whitmore | 10% Owner | 2023-10-31 | 70,812 | $0.73 | $51.55kBuy |
| Bradford T. Whitmore | 10% Owner | 2023-10-30 | 600 | $0.69 | $411.00Buy |
| Nancy J. Hutson | Director | 2023-10-03 | 10,000 | $0.86 | $8.60kBuy |
CLSD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CLSD insiders and whales buy or sell their stock.
CLSD Shareholders
What type of owners hold Clearside Biomedical Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Clay Thorp | 9.39% | 7,019,083 | $9.27M | Insider |
| Bradford T. Whitmore | 9.16% | 6,845,186 | $9.04M | Insider |
| Hatteras Venture Advisors Iv Sbic LLC | 5.55% | 4,150,684 | $5.48M | Insider |
| Hatteras Venture Advisors Iii LLC | 4.74% | 3,540,739 | $4.67M | Insider |
| Vanguard Group Inc | 2.91% | 2,176,316 | $2.87M | Institution |
| Carmignac Gestion | 2.85% | 2,132,744 | $2.82M | Institution |
| Cormorant Asset Management LP | 2.66% | 1,988,208 | $2.62M | Insider |
| Rmi Investments Sarl | 2.09% | 1,558,024 | $2.06M | Insider |
| Blackrock Inc | 1.02% | 759,743 | $1.00M | Institution |
| Daniel H. White | 0.70% | 519,832 | $686.18k | Insider |
CLSD vs Biotech Stocks
Clearside Biomedical Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.